Search research articles
Contact Us
Filters
Showing results (61-70 of 320) with videos related to
Page
of 32
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
June 1, 2022
Time to First Subsequent Salvage Therapy in Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia Treated With Inotuzumab Ozogamicin in the Phase III INO-VATE Trial
Matthias Stelljes, Anjali S Advani, Daniel J DeAngelo, et al.
British Journal of Haematology
|
March 21, 2022
Orthopaedic adverse events among adolescents and adults treated with asparaginase for acute lymphoblastic leukaemia
Yannis K Valtis, Andrew E Place, Lewis B Silverman, et al.
Journal of Clinical Pathology
|
March 29, 2018
Flow cytometric minimal residual disease assessment of peripheral blood in acute lymphoblastic leukaemia patients has potential for early detection of relapsed extramedullary disease
Alissa Keegan, Karry Charest, Ryan Schmidt, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 6, 2011
Candida albicans cervical lymphadenitis in patients who have acute myeloid leukemia
Marcella M Alsan, Nicolas C Issa, Sarah P Hammond, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 16, 2015
Reproducibility and prognostic significance of morphologic dysplasia in de novo acute myeloid leukemia
Olga K Weinberg, Olga Pozdnyakova, Federico Campigotto, et al.
American Journal of Hematology
|
November 2, 2012
An extreme example of focal bone marrow involvement in acute myeloid leukemia
Charlotte K Brierley, Elizabeth A Morgan, Julian R Sprague, et al.
Blood
|
October 22, 2003
Fatal hepatic necrosis following imatinib mesylate therapy
Nancy U Lin, Stefanie Sarantopoulos, James R Stone, et al.
Journal of Oncology Practice
|
August 15, 2013
Impact of physician assistants on the outcomes of patients with acute myelogenous leukemia receiving chemotherapy in an academic medical center
Brett E Glotzbecker, Deborah S Yolin-Raley, Daniel J DeAngelo, et al.
Blood Reviews
|
February 22, 2023
Why do we not have more drugs approved for MDS? A critical viewpoint on novel drug development in MDS
Stacey M Frumm, Shai Shimony, Richard M Stone, et al.
Journal of Hematology & Oncology
|
December 28, 2018
Management of adverse events associated with bosutinib treatment of chronic-phase chronic myeloid leukemia: expert panel review
Jorge E Cortes, Jane F Apperley, Daniel J DeAngelo, et al.
Page
of 32
Search research articles
Search
Showing results (61-70 of 320) with videos related to
Sort By:
Page
of 32
Clinical Lymphoma, Myeloma & Leukemia
|
June 1, 2022
Time to First Subsequent Salvage Therapy in Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia Treated With Inotuzumab Ozogamicin in the Phase III INO-VATE Trial
Matthias Stelljes, Anjali S Advani, Daniel J DeAngelo, et al.
British Journal of Haematology
|
March 21, 2022
Orthopaedic adverse events among adolescents and adults treated with asparaginase for acute lymphoblastic leukaemia
Yannis K Valtis, Andrew E Place, Lewis B Silverman, et al.
Journal of Clinical Pathology
|
March 29, 2018
Flow cytometric minimal residual disease assessment of peripheral blood in acute lymphoblastic leukaemia patients has potential for early detection of relapsed extramedullary disease
Alissa Keegan, Karry Charest, Ryan Schmidt, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 6, 2011
Candida albicans cervical lymphadenitis in patients who have acute myeloid leukemia
Marcella M Alsan, Nicolas C Issa, Sarah P Hammond, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 16, 2015
Reproducibility and prognostic significance of morphologic dysplasia in de novo acute myeloid leukemia
Olga K Weinberg, Olga Pozdnyakova, Federico Campigotto, et al.
American Journal of Hematology
|
November 2, 2012
An extreme example of focal bone marrow involvement in acute myeloid leukemia
Charlotte K Brierley, Elizabeth A Morgan, Julian R Sprague, et al.
Blood
|
October 22, 2003
Fatal hepatic necrosis following imatinib mesylate therapy
Nancy U Lin, Stefanie Sarantopoulos, James R Stone, et al.
Journal of Oncology Practice
|
August 15, 2013
Impact of physician assistants on the outcomes of patients with acute myelogenous leukemia receiving chemotherapy in an academic medical center
Brett E Glotzbecker, Deborah S Yolin-Raley, Daniel J DeAngelo, et al.
Blood Reviews
|
February 22, 2023
Why do we not have more drugs approved for MDS? A critical viewpoint on novel drug development in MDS
Stacey M Frumm, Shai Shimony, Richard M Stone, et al.
Journal of Hematology & Oncology
|
December 28, 2018
Management of adverse events associated with bosutinib treatment of chronic-phase chronic myeloid leukemia: expert panel review
Jorge E Cortes, Jane F Apperley, Daniel J DeAngelo, et al.
Page
of 32